How research support has helped create life-changing medicines
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid leukemia. This form of cancer was once regarded as very difficult to combat, but survival rates of patients who respond to Gleevec now resemble that of the population at large.
Gleevec is also a medicine developed with the help of federally funded research. That support helped scientists better understand how to create drugs targeting the BCR-ABL oncoprotein, the cancer-causing protein behind chronic myeloid ...